Is CYRX or DCOY more undervalued in 2026?

CirclFi compares CryoPort, Inc. (CYRX) and Decoy Therapeutics Inc. (DCOY) using 13 institutional-grade valuation models. CYRX has a Quality of Company score of 6.7/10 while DCOY scores 3.7/10.

Which is a better buy — CYRX or DCOY?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CYRX and DCOY valuations compare?

CYRX at $15.69 and DCOY at $8.92 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CYRX vs DCOY Valuation Comparison 2026 — Intrinsic Value Analysis

CYRX

Pharmaceutical Preparations

CryoPort, Inc.

Quality

6.7

out of 10

Value Trap

—

Price

$15.69

Last close

Models

13/13

Active

DCOY

Pharmaceutical Preparations

Decoy Therapeutics Inc.

Quality

3.7

out of 10

Value Trap

LOW

Price

$8.92

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	CYRX Fair Value	CYRX Upside	DCOY Fair Value	DCOY Upside
Bayesian DCF	Intrinsic	$5.63	-64.1%	$9.54	+6.9%
Earnings Power Value	Intrinsic	$25.98	+151.0%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$2.52	-80.8%	$0.72	-87.8%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CYRX vs DCOY — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CYRX vs DCOY — Which Stock Is More Undervalued?

CYRX scores higher with a 6.7/10 quality rating vs DCOY's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing CryoPort, Inc. (CYRX) and Decoy Therapeutics Inc. (DCOY) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CYRX currently trades at $15.69 with a QOC of 6.7/10, while DCOY trades at $8.92 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).